PDK1 and neoplasm: Based on the results of our study, we inferred that PDK1 protected BCL-2, BCL-xL, and PI3K/Akt/mTOR from degradation and that the persistent stabilization of these proteins made the tumor cells resistant to apoptosis, thus conferring survival advantages.